Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. - Test2 - elhamkhani - TriplyDB

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

http://www.wikidata.org/entity/Q27303466

about

Pathophysiological power of improper tonic GABA(A) conductances in mature and immature models.Alterations of GABAergic signaling in autism spectrum disorders Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function Emerging pharmacotherapies for neurodevelopmental disorders Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases Altered Neuronal and Circuit Excitability in Fragile X Syndrome.Prenatal stress and inhibitory neuron systems: implications for neuropsychiatric disorders Fragile X syndrome and targeted treatment trials.GABAergic signaling as therapeutic target for autism spectrum disorders Functional regulation of GABAA receptors in nervous system pathologies The FMRP regulon: from targets to disease convergence Inhibition-Based Biomarkers for Autism Spectrum Disorder.The unstable repeats--three evolving faces of neurological disease Animal models of intellectual disability: towards a translational approach A dual comparative approach: integrating lines of evidence from human evolutionary neuroanatomy and neurodevelopmental disorders Translational regulation of NeuroD1 expression by FMRP: involvement in glutamatergic neuronal differentiation of cultured rat primary neural progenitor cells Regulation of GABAA receptors by fragile X mental retardation protein GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.Progress toward therapeutic potential for AFQ056 in Fragile X syndrome.The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome.From FMRP function to potential therapies for fragile X syndrome.Impaired critical period plasticity in primary auditory cortex of fragile X model mice Resilience to audiogenic seizures is associated with p-ERK1/2 dephosphorylation in the subiculum of Fmr1 knockout mice.The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.Potential therapeutic interventions for fragile X syndrome Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome Circuit level defects in the developing neocortex of Fragile X mice.Imbalanced pattern completion vs. separation in cognitive disease: network simulations of synaptic pathologies predict a personalized therapeutics strategy.Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives.Altered GABAergic markers, increased binocularity and reduced plasticity in the visual cortex of Engrailed-2 knockout mice.Deficient tonic GABAergic conductance and synaptic balance in the fragile X syndrome amygdala Adeno-associated virus-mediated rescue of the cognitive defects in a mouse model for Angelman syndrome.Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.Modulation of the GABAergic pathway for the treatment of fragile X syndrome.Cell type-specific properties of subicular GABAergic currents shape hippocampal output firing mode Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models.Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus A computational model for cerebral cortical dysfunction in autism spectrum disorders.Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.

P2860

Q21129461-87AB02A0-9D5E-4983-B3FE-B24D298DB442 Q21296802-4A877E4E-E233-4FF7-87D3-9E71E9B695FD Q24608468-89A4F77E-1760-4C20-A88E-3361A0F9B6FC Q24619170-2CA58346-9EED-4D6F-8B43-4BC17FD53A7C Q26781265-1E9DE280-DC01-44AF-9196-54AB11638BEC Q26786331-80E86963-85DA-4FD0-83E7-AABA58E79F9C Q26796317-EC487393-8F86-412E-8FC4-5FC70D9C1326 Q26829786-3D0A1B1F-94C9-4E47-A3E8-1819FDBD7A14 Q26865162-F497F3C1-7315-4F42-8D4E-5ABBBAC4B3B1 Q27013583-59326451-B87A-46ED-944B-4DF52F3C7D32 Q27013597-E72B669F-D4ED-431A-A0E7-BDDACBFAB4DF Q27014002-42E42577-26A9-4210-B46E-49676A6D9F6D Q27015696-F0995FEA-1ADD-477E-8203-B7CD12EFBC9A Q27025923-784BFB94-CA9D-40D1-980E-EB24354B3B9C Q28389500-CAD49278-31F5-458A-B7A7-3D3A0A42C106 Q28655504-10269137-D4C3-4A07-9ED4-A80F4F16263F Q28771393-D385F506-D058-4E54-9E1F-16AB4C655B98 Q29568316-1DC3707C-263B-4BB4-8FC2-F06CAFE9C1F9 Q30363617-00800CBB-905C-49AC-A2BF-4C799C5AB81E Q30383696-E2BCFFE0-1959-4870-879C-48D36E65F5B4 Q30385019-E3504552-7674-4963-AA06-E0585C2E3DBC Q30410502-3EFE9663-EAD7-4224-9509-7C0F6A59A9A0 Q30440653-C748CB80-A0A9-4D47-A862-A49DC1DA745B Q30455160-E6CCF21E-C735-44F8-A9BF-99BC878EFA07 Q30461456-15A292FE-4BFB-484A-8C0A-C9DF23630F4E Q30473378-5BE56631-F72B-44E6-BAA7-2FEAA1028D7C Q30496828-DC502585-49D1-43BB-A0EF-4CDFC087B0C9 Q30540967-5854AE65-30C2-4C8D-8E65-6924D1F9F991 Q33655637-50B398AD-7C23-4007-A40D-F3B7A224CCB3 Q33659830-B50BD71B-65AA-4E05-BA30-51EA447CB637 Q33765086-2575FA46-0B92-46A5-B24C-12B2C0D3A0F8 Q34006575-66C87267-5B81-42C2-B67D-025548B9C275 Q34102843-51182756-A6A4-48FA-8E27-34EC1F9CEDF8 Q34198650-FFDD73CE-B3DD-4C43-91C6-A3976CE93B4F Q34230612-B915E17F-965D-4577-933D-5CCB49589E87 Q34515743-A0637F02-D778-4A87-B52E-62A2CA85B1EC Q34689960-4B7F06A1-5C96-4AC1-8925-8D8B80C223FA Q34773158-ED100731-1FA5-4449-8A15-4E71E4A88FF0 Q35014681-4577F6EF-9B52-4BB3-97CE-C30071871425 Q35188148-846D1853-BE76-4848-AA5D-7B011CF4B944

P2860

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

http://www.wikidata.org/entity/Q27303466

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome

@nl

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

@ast

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

@en

type

label

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome

@nl

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

@ast

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

@en

prefLabel

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome

@nl

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

@ast

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

@en

P1433

Q27303466-3AC3776E-223C-485E-8D38-3970BFF3B2BD

P1476

Q27303466-F47D276E-9B56-44FC-BEF5-BCD1E5EE2796

P2093

Q27303466-05FBF026-1F45-4248-9EB1-C5AE961718B2

Q27303466-5C0CCC0B-ADEE-4853-B04B-22A5661B29CF

Q27303466-6E7CA4A2-F3B4-4156-87EC-92CD36A2A25B

Q27303466-DCB7AF68-1B54-4097-A7D7-9E4C701B50ED

P2860

Q27303466-07B2CBEF-5E94-4D2C-A2FD-D5C6FF5A3C74

Q27303466-10F0EC9C-59D5-4511-A696-656494401D88

Q27303466-1347E88E-1982-41F7-B2A7-66E4498CBF4E

Q27303466-17A32451-06EF-4DB6-90B9-E66A62E5F0D8

Q27303466-1AC80524-A173-4CDF-8D1E-A666E5455E3F

Q27303466-235EC466-827D-4D6E-BEF9-B343D85C11F3

Q27303466-25338733-03F4-40A9-8826-C139558B529D

Q27303466-2D642D57-04E3-433B-BF7A-1B27F3E1993C

Q27303466-30DB622C-62D4-4E40-BB7A-B032C585D9E0

Q27303466-3C8C8481-6BFA-4A96-AA86-9B3EAACF3C8A

P304

Q27303466-687D79F0-7152-4F8D-85A7-0A13E12FDC86

P31

Q27303466-0EFE9196-9BEF-4925-A8F1-31E6E3A0327B

P356

Q27303466-D0F694E1-4781-4D99-A2F8-7804873F427D

P407

Q27303466-D4BAD308-B0C6-4627-9AE9-8BAC8D9891D3

P433

Q27303466-EA9C108C-4374-42C7-98F6-3D370B0C4736

P478

Q27303466-7D6672EA-5B0E-4FB0-A1BF-04983EA69A63

P577

Q27303466-D3F7E226-20CF-47FC-8A6C-5A45F32858A3

P698

Q27303466-B4D3DE0A-3468-4A8B-8042-E68B78B8C3DB

P932

Q27303466-69F55BC2-1DF4-4E69-B3F4-6FF984C34AFE

P356

P1433

Cerebral Cortex

P1476

Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

@en

P2093

Giulia Curia

http://www.w3.org/2001/XMLSchema#string

Massimo Avoli

http://www.w3.org/2001/XMLSchema#string

Philippe Séguéla

http://www.w3.org/2001/XMLSchema#string

Thomas Papouin

http://www.w3.org/2001/XMLSchema#string

P2860

Altered synaptic plasticity in a mouse model of fragile X mental retardation

A new mathematical model for relative quantification in real-time RT-PCR

The fragile X gene and its function

Guideline to reference gene selection for quantitative real-time PCR

Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses

The mGluR theory of fragile X mental retardation

Short-term steroid treatment increases delta GABAA receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects.

The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95.

The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain.

The human gamma-aminobutyric acid A receptor delta (GABRD) gene: molecular characterisation and tissue-specific expression.

P304

1515-1520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CERCOR/BHN159

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18787232

http://www.w3.org/2001/XMLSchema#string

P932

4873279

http://www.w3.org/2001/XMLSchema#string